1,295
Views
38
CrossRef citations to date
0
Altmetric
Original Research Article

Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use

ORCID Icon, , , , , , ORCID Icon, , & show all
Pages 45-51 | Received 20 Oct 2017, Accepted 23 Dec 2017, Published online: 11 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Andrea R. Genazzani, Tiziana Fidecicchi, Domenico Arduini, Andrea Giannini & Tommaso Simoncini. (2023) Hormonal and natural contraceptives: a review on efficacy and risks of different methods for an informed choice. Gynecological Endocrinology 39:1.
Read now
Cerisa Obern, Maria Ekstrand Ragnar, Tanja Tydén, Margareta Larsson, Jenny Niemeyer Hultstrand, Kristina Gemzell-Danielsson, Inger Sundström-Poromaa & Marlene Makenzius. (2023) Multiple induced abortions – implications for counselling and contraceptive services from a multi-centre cross-sectional study in Sweden. The European Journal of Contraception & Reproductive Health Care 28:2, pages 119-124.
Read now
Susanna Svahn, Jenny Niemeyer Hultstrand, Tanja Tydén & Maria Ekstrand Ragnar. (2021) Contraception use and attitudes: women’s concerns regarding hormonal contraception and copper intrauterine devices. The European Journal of Contraception & Reproductive Health Care 26:6, pages 473-478.
Read now
Andrea J Rapkin, Yelena Korotkaya & Kathrine C Taylor. (2019) Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives. Open Access Journal of Contraception 10, pages 27-39.
Read now
J. Bitzer, A. Rapkin & C. N. Soares. (2018) Managing the risks of mood symptoms with LNG-IUS: a clinical perspective. The European Journal of Contraception & Reproductive Health Care 23:5, pages 321-325.
Read now
Jóna Kristjánsdóttir, Claes Sundelin & Tord Naessen. (2018) Health-related quality of life in young women starting hormonal contraception: a pilot study . The European Journal of Contraception & Reproductive Health Care 23:3, pages 171-178.
Read now

Articles from other publishers (32)

Summer Mengelkoch, Jeffrey Gassen, George M. Slavich & Sarah E. Hill. (2024) Hormonal contraceptive use is associated with differences in women’s inflammatory and psychological reactivity to an acute social stressor. Brain, Behavior, and Immunity 115, pages 747-757.
Crossref
Maria Forslund, Johanna Melin, Simon Alesi, Terhi Piltonen, Daniela Romualdi, Chau Thien Tay, Selma Witchel, Alexia Pena, Aya Mousa & Helena Teede. (2023) Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis. European Journal of Endocrinology 189:1, pages S1-S16.
Crossref
Søren Vinther Larsen, Anders Pretzmann Mikkelsen, Øjvind Lidegaard & Vibe Gedso Frokjaer. (2023) Depression Associated With Hormonal Contraceptive Use as a Risk Indicator for Postpartum Depression. JAMA Psychiatry 80:7, pages 682.
Crossref
Cecilia Lundin, Anna Wikman, Per Wikman, Helena Kopp Kallner, Inger Sundström-Poromaa & Charlotte Skoglund. (2023) Hormonal Contraceptive Use and Risk of Depression Among Young Women With Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry 62:6, pages 665-674.
Crossref
Belinda Pletzer, Katharina Winkler-Crepaz & Katharina Maria Hillerer. (2023) Progesterone and contraceptive progestin actions on the brain: A systematic review of animal studies and comparison to human neuroimaging studies. Frontiers in Neuroendocrinology 69, pages 101060.
Crossref
Sarah E. Hill & Summer Mengelkoch. (2023) Moving beyond the mean: Promising research pathways to support a precision medicine approach to hormonal contraception. Frontiers in Neuroendocrinology 68, pages 101042.
Crossref
Elizabeth Hampson. (2023) Oral contraceptives in the central nervous system: Basic pharmacology, methodological considerations, and current state of the field. Frontiers in Neuroendocrinology 68, pages 101040.
Crossref
Kelly L. Klump & Alaina M. Di Dio. (2022) Combined oral contraceptive use and risk for binge eating in women: Potential gene × hormone interactions. Frontiers in Neuroendocrinology 67, pages 101039.
Crossref
Adriene M. Beltz. (2022) Hormonal contraceptive influences on cognition and psychopathology: Past methods, present inferences, and future directions. Frontiers in Neuroendocrinology 67, pages 101037.
Crossref
Natalie C. Tronson & Kristen M. Schuh. (2022) Hormonal contraceptives, stress, and the brain: The critical need for animal models. Frontiers in Neuroendocrinology 67, pages 101035.
Crossref
Carina Heller, Ann-Christin S. Kimmig, Marek R. Kubicki, Birgit Derntl & Zora Kikinis. (2022) Imaging the human brain on oral contraceptives: A review of structural imaging methods and implications for future research goals. Frontiers in Neuroendocrinology 67, pages 101031.
Crossref
Bronwyn M. Graham. (2022) The impact of hormonal contraceptives on anxiety treatments: From preclinical models to clinical settings. Frontiers in Neuroendocrinology 67, pages 101030.
Crossref
Anne Marieke Doornweerd, Susan Branje, Stefanie A. Nelemans, Wim H. J. Meeus, Estrella R. Montoya, Iris M. Engelhard, Joke M. P. Baas & Lotte Gerritsen. (2022) Stable Anxiety and Depression Trajectories in Late Adolescence for Oral Contraceptive Users. Frontiers in Psychiatry 13.
Crossref
Carolin A. Lewis, Ann-Christin S. Kimmig, Nils B. Kroemer, Shakoor Pooseh, Michael N. Smolka, Julia Sacher & Birgit Derntl. (2022) No Differences in Value-Based Decision-Making Due to Use of Oral Contraceptives. Frontiers in Endocrinology 13.
Crossref
Rossella E. Nappi, Laura Cucinella, David Bosoni, Alessandra Righi, Federica Battista, Pietro Molinaro, Giulia Stincardini, Manuela Piccinino, Roberta Rossini & Lara Tiranini. (2022) Premenstrual Syndrome and Premenstrual Dysphoric Disorder as Centrally Based Disorders. Endocrines 3:1, pages 127-138.
Crossref
Elena Toffol, Timo Partonen, Oskari Heikinheimo, Anna But, Antti Latvala & Jari Haukka. (2022) Associations between use of psychotropic medications and use of hormonal contraception among girls and women aged 15–49 years in Finland: a nationwide, register-based, matched case–control study. BMJ Open 12:2, pages e053837.
Crossref
Torbjörn Bäckström, Karin Ekberg, Angelica Lindén Hirschberg, Marie Bixo, C. Neill Epperson, Paula Briggs, Nick Panay & Shaughn O’Brien. (2021) A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder. Psychoneuroendocrinology 133, pages 105426.
Crossref
Margot W.L. Morssinkhof, Femke Lamers, Adriaan W. Hoogendoorn, Anouk E. de Wit, Harriëtte Riese, Erik J. Giltay, Odile A. van den Heuvel, Brenda W. Penninx & Birit F.P. Broekman. (2021) Oral contraceptives, depressive and insomnia symptoms in adult women with and without depression. Psychoneuroendocrinology 133, pages 105390.
Crossref
Christine Kuehner & Sibel Nayman. (2021) Premenstrual Exacerbations of Mood Disorders: Findings and Knowledge Gaps. Current Psychiatry Reports 23:11.
Crossref
Sofia Zettermark, Kani Khalaf, Raquel Perez-Vicente, George Leckie, Diana Mulinari & Juan Merlo. (2021) Population heterogeneity in associations between hormonal contraception and antidepressant use in Sweden: a prospective cohort study applying intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA). BMJ Open 11:10, pages e049553.
Crossref
Cecilia Lundin, Anna Wikman, Marie Bixo, Kristina Gemzell-Danielsson & Inger Sundström Poromaa. (2021) Towards individualised contraceptive counselling: clinical and reproductive factors associated with self-reported hormonal contraceptive-induced adverse mood symptoms. BMJ Sexual & Reproductive Health 47:3, pages e1.1-e8.
Crossref
Sang Min Lee & Jin Kyung Park. (2021) Dienogest-induced major depressive disorder with suicidal ideation. Medicine 100:40, pages e27456.
Crossref
Inger Sundström-Poromaa. 2021. Female and Male Contraception. Female and Male Contraception 45 56 .
Franca Fruzzetti & Tiziana Fidecicchi. (2020) Hormonal Contraception and Depression: Updated Evidence and Implications in Clinical Practice. Clinical Drug Investigation 40:12, pages 1097-1106.
Crossref
Rupali Sharma, Zhuo Fang, Andra Smith & Nafissa Ismail. (2020) Oral contraceptive use, especially during puberty, alters resting state functional connectivity. Hormones and Behavior 126, pages 104849.
Crossref
Elena Toffol, Anna But, Oskari Heikinheimo, Antti Latvala, Timo Partonen & Jari Haukka. (2020) Associations between hormonal contraception use, sociodemographic factors and mental health: a nationwide, register-based, matched case–control study. BMJ Open 10:10, pages e040072.
Crossref
Inger Sundström-Poromaa, Erika Comasco, Rachael Sumner & Eileen Luders. (2020) Progesterone – Friend or foe?. Frontiers in Neuroendocrinology 59, pages 100856.
Crossref
Andrea Scheuringer, Cecilia Lundin, Birgit Derntl, Belinda Pletzer & Inger Sundström Poromaa. (2020) Use of an estradiol-based combined oral contraceptives has no influence on attentional bias or depressive symptoms in healthy women. Psychoneuroendocrinology 113, pages 104544.
Crossref
Carolin A. Lewis, Ann-Christin S. Kimmig, Rachel G. Zsido, Alexander Jank, Birgit Derntl & Julia Sacher. (2019) Effects of Hormonal Contraceptives on Mood: A Focus on Emotion Recognition and Reactivity, Reward Processing, and Stress Response. Current Psychiatry Reports 21:11.
Crossref
Charlotte Skoglund, Helena Kopp Kallner, Alkistis Skalkidou, Anna-Karin Wikström, Cecilia Lundin, Susanne Hesselman, Anna Wikman & Inger Sundström Poromaa. (2019) Association of Attention-Deficit/Hyperactivity Disorder With Teenage Birth Among Women and Girls in Sweden. JAMA Network Open 2:10, pages e1912463.
Crossref
Filippo Maria Nimbi, Roberta Rossi, Francesca Tripodi, Kevan Wylie & Chiara Simonelli. (2019) A Biopsychosocial Model for the Counseling of Hormonal Contraceptives: A Review of the Psychological, Relational, Sexual, and Cultural Elements Involved in the Choice of Contraceptive Method. Sexual Medicine Reviews 7:4, pages 587-596.
Crossref
Stephanie Laird, Luke J. Ney, Kim L. Felmingham & Andrea Gogos. (2019) Hormonal Contraception and the Brain: Examining Cognition and Psychiatric Disorders. Current Psychiatry Research and Reviews 15:2, pages 116-131.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.